Group items tagged

A study has revealed that understanding the genetic and molecular structure of individual breast tumours could provide information on cancer progression and recurrence.

Stryker has acquired Israeli OrthoSpace for a total cash consideration of $220m. The deal involves an upfront payment of $110m, followed by an additional payment of up to $110m for future milestones.

Biotronik has secured approval from the US Food and Drug Administration (FDA) for the use of its Acticor and Rivacor cardiac rhythm management (CRM) devices to treat heart arrhythmias.

Researchers from Ohio State University have identified the specific biomarkers of fibromyalgia, differentiating it from other related diseases.

A study presented at the ESTRO 38 conference in Milan, Italy, has indicated that a type of radiotherapy called pencil beam scanning proton therapy (PBS) offers the best hope for preserving cognitive functions in children with craniopharyngioma brain tumours.

Researchers at the University of Michigan Kellogg Eye Center have demonstrated the effectiveness of a smartphone technology which combines high-quality retinal imaging with artificial intelligence (AI) to enable the early detection of diabetic retinopathy (DR).

Steen Solution Perfusate to heSwedish medical technology firm Xvivo Perfusion has received the US Food and Drug Administration (FDA) approval for the use of its Xvivo Perfusion System with lp in lung transplant procedure.

Researchers from the Stanford University School of Medicine have devised a new blood test for the identification of chronic fatigue syndrome (CFS), a debilitating condition that lacks a standard diagnostic test.

The US Food and Drug Administration (FDA) has granted approval to Medtronic's Attain Stability Quad MRI SureScan left heart lead. The device is the only active-fixation left heart lead, and is designed for precise lead placement and stability.

A research team at University of Washington in the US has developed software that leverages a small paper funnel and a smartphone's microphone and speaker to detect ear infections in children.

Material sciences company W. L. Gore & Associates has received approval from the US Food and Drug Administration (FDA) for its Tag Conformable Thoracic Stent Graft, a thoracic endovascular aortic repair (TEVAR) device.

Israeli company Zebra Medical Vision has secured 510(k) clearance from the US Food and Drug Administration (FDA) for an artificial intelligence (AI)-powered chest X-ray triage product.

An algorithm has learned how to identify imaging patterns correlating to heart attack and death in cardiac patients and can predict the occurrence of these events with superior accuracy to human doctors, according to a study presented at 2019's International Conference on Nuclear Cardiology and Cardiac CT (ICNC) in Lisbon, Portugal.

Researchers at Canada's University of British Columbia have developed a laser microscope to enable diagnosis and treatment of diseases, including skin cancer, without the need for cutting the skin.

US-based medical technology company Xenco Medical has launched the first interactive vending machines for spine surgery instruments and implants.

University of Warwick spin-out Verdel Instruments has raised seed funding of over £230,000 from Longwall Ventures and British public innovation agency Innovate UK to develop a new two-dimensional mass spectrometry (2DMS) technology.

A team of Belgian researchers are using artificial intelligence (AI) to identify the causes of rare disease and improve their diagnosis.

3D printing solutions provider Materialise has obtained clearance for its Mimics Enlight cardiovascular planning software suite from the US Food and Drug Administration (FDA).

Robotic and prosthetic devices may one day be equipped with a sense of touch equivalent to or better than human skin. A research team at the National University of Singapore (NUS) has developed the Asynchronous Coded Electronic Skin (ACES) system, which can sense touch at 1,000 times the speed of the human nervous system.

Senior doctors have called for a crackdown on the sale of home genetic testing kits, following a surge in the number of patients being wrongly informed they are carrying serious genetic mutations.